Furthermore, systemic administration of antibodies against the binding site of CgA1-373 for neuropilin-1 (PGPQLR), an important receptor for its pro-angiogenic activity (8), significantly reduced Panc02-tumor growth (Figure 5). This evidence concerns the gene NRP1 and neoplasm.